Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets
Tafireyi Marukutira, Dwight Yin, Laura Cressman, Ruth Kariuki, Brighid Malone, Tim Spelman, Shreshth Mawandia, Jenny H Ledikwe, Bazghina-Werq Semo, Suzanne Crowe, Mark Stoove, Margaret Hellard, Diana Dickinson
Medicine | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
The aim of the study was to evaluate the human immunodeficiency virus (HIV) treatment cascade and mortality in migrants and citizens living with HIV in Botswana.Retrospective 2002 to 2016 cohort study using electronic medical records from a single center managing a high migrant case load.Records for 768 migrants and 3274 citizens living with HIV were included. Maipelo Trust, a nongovernmental organization, funded care for most migrants (70%); most citizens (85%) had personal health insurance. Seventy percent of migrants and 93% of citizens had received antiretroviral therapy (ART). At study end, 44% and 27% of migrants and citizens, respectively were retained in care at the clinic (P < .001)..View full abstract
TM is supported by the Australian Government for his PhD studies. MH receives a Fellowship from the National Health and Medical Research Council of Australia and an investigator initiated funding from Gilead Sciences, Abbvie, and GSK for research unrelated to HIV care. The remaining authors report no conflicts of interest.